Therapeutic targeting of the DNA damage mediators CHK1 and Wee1 in neuroblastoma

被引：0
作者：
Russell, Mike [1 ]
Levin, Kirill [1 ]
Rader, JulieAnn [1 ]
Toniatti, Carlo [2 ]
Maris, John M. [1 ]
Cole, Kristina A. [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Merck Res Labs, Boston, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1436
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ATR/CHK1/WEE1 Dependency in SRSF2-Mutated MDS/AML
    Eldfors, Samuli
    Rai, Sumit
    Sharma, Vineet
    Gilbert, Angelique N.
    Porkka, Kimmo
    Graubert, Timothy A.
    BLOOD, 2021, 138 : 3661 - +
  • [22] Direct Targeting of the Cell cycle Regulator WEE1 is a Novel Therapeutic Approach for Neuroblastoma
    Suri, Parul
    Chilamakuri, Rameswari
    Agarwal, Saurabh
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [23] ATR/CHK1/WEE1 DEPENDENCY IN SRSF2-MUTATED MDS/AML
    Eldfors, Samuli
    Rai, Sumit
    Sharma, Vineet
    Hossan, Tareq
    Cabrera, Claudia
    Bertino, Amy
    Gilbert, Angelique
    Walter, Matthew
    Porkka, Kimmo
    Graubert, Timothy
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [24] Inhibition of Chk1 and Wee1 as an effective therapeutic approach in diffuse large B cell lymphomas: A way to target Myc?
    Vagni, M.
    Restelli, V.
    Lupi, M.
    Damia, G.
    Carrassa, L.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S122 - S122
  • [25] The blockade of DNA damage response increase the sensitivity of CHK1 inhibitor in neuroblastoma
    Ando, Kiyohiro
    Nakamura, Yohko
    Koshinaga, Tsugumichi
    Makishima, Makoto
    CANCER SCIENCE, 2018, 109 : 1139 - 1139
  • [26] Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells
    Mak, Joyce P. Y.
    Man, Wing Yu
    Chow, Jeremy P. H.
    Ma, Hoi Tang
    Poon, Randy Y. C.
    ONCOTARGET, 2015, 6 (25) : 21074 - 21084
  • [27] Targeting Chk1
    Eastman, Alan R.
    MOLECULAR CANCER RESEARCH, 2017, 15
  • [28] Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
    Bukhari, Amirali B.
    Chan, Gordon K.
    Gamper, Armin M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine
    Koh, Siang-Boon
    Wallez, Yann
    Dunlop, Charles R.
    Fernandez, Sandra Bernaldo de Quiros
    Bapiro, Tashinga E.
    Richards, Frances M.
    Jodrell, Duncan I.
    CANCER RESEARCH, 2018, 78 (11) : 3054 - 3066
  • [30] EVALUATION OF BBB PERMEABLE WEE1 AND CHK1 INHIBITORS IN COMBINATION WITH STANDARD OF CARE FOR THE TREATMENT OF GLIOBLASTOMA
    Scholefield, E. L.
    Gomez-Roman, N.
    NEURO-ONCOLOGY, 2024, 26 : V72 - V72
12345